Screener
Celldex Therapeutics CLDX Business Segments — Supplies Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SuppliesExpense.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Personnel | $15,885 | $14,129 | $31,454 | $27,729 |
| Laboratory supplies | 2,593 | 1,544 | 4,051 | 3,712 |
| Facility | 1,178 | 1,398 | 2,118 | 2,803 |
| Product development (b) | 41,746 | 33,536 | 91,903 | 65,702 |
| Other expenses (c) | 6,140 | 3,589 | 11,017 | 6,864 |
| Total R&D expense | $67,542 | $54,196 | $140,543 | $106,810 |
Item 1. Unaudited Financial Statements
FAQ
- What is Celldex Therapeutics's business segments — supplies expense?
- Celldex Therapeutics (CLDX) reported business segments — supplies expense of $2.59M in Q2 2026.
- How has Celldex Therapeutics's business segments — supplies expense changed year-over-year?
- Celldex Therapeutics's business segments — supplies expense increased by 67.9% year-over-year, from $1.54M to $2.59M.
- What is the long-term trend for Celldex Therapeutics's business segments — supplies expense?
- Over 3 years (2022 to 2025), Celldex Therapeutics's business segments — supplies expense has grown at a -1.7% compound annual growth rate (CAGR), from $6.31M to $6M.
- What does business segments — supplies expense mean?
- This metric tracks the costs of materials, laboratory consumables, and other physical supplies consumed during the research and development process within the primary business segment. It serves as a measure of the operational intensity of the company's clinical and laboratory activities. Fluctuations in this metric can indicate changes in the volume or complexity of ongoing experimental programs.
Ask your AI about Celldex Therapeutics's business segments — supplies expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude